Adjunctive Role of PRF After Free Gingival Graft Harvesting - Case Series
NCT ID: NCT02521467
Last Updated: 2015-08-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
10 participants
INTERVENTIONAL
2014-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
PRF for Accelerating Palatal Healing
NCT02712242
Effects of Platelet Concentrates on Palatal Wound Healing
NCT04097509
Effect of PRF Palatal Bandage on Pain Scores and Wound Healing After Free Gingival Graft
NCT02797899
Platelet Rich Fibrin in the Treatment of Palatal Wounds
NCT02438046
Platelet Rich Fibrin in the Treatment of Full Thickness Palatal Wounds
NCT04043039
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Free gingival grafts are one of the common treatment modalities used to increase the zone of keratinized tissue (KT) around implants or prior to ridge augmentation and root coverage. The palatal donor sites had many complications as pain, discomfort and healing by secondary intention. Platelets Rich Fibrin (PRF) is a second generation of platelets concentrate full of growth factors fasten the healing and decrease the pain.
Materials and methods:
Ten patients requiring augmentation of KT participated in this case series. The palatal donor sites of 7 of these patients were covered with PRF membranes with a new suturing technique without palatal stent, the other 3 had palatal stent. Palatal tissue will examined clinically after 3, 7, 10 and 14 days. Considerably very fast healing with 0 pain score was observed during one week in the group with PRF.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PRF
Platelets Rich Fibrin
Platelets Rich Fibrin in healing of palatal donor tissue
Platelets Rich Fibrin (PRF) is a second generation of platelets concentrate full of growth factors as PDGF, IGF, TGF which had a role in hemostasis fasten the healing and decrease the pain.
palatal stent
Palatal stent
Placebo
the other group is a control group, had no biologic in the palatal wound, only palatal stent
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Platelets Rich Fibrin in healing of palatal donor tissue
Platelets Rich Fibrin (PRF) is a second generation of platelets concentrate full of growth factors as PDGF, IGF, TGF which had a role in hemostasis fasten the healing and decrease the pain.
Placebo
the other group is a control group, had no biologic in the palatal wound, only palatal stent
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
20 Years
45 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ain Shams University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Doaa Adel Salah Khattab
Assistant Lecturer Oral Periodontology Department
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Doaa Adel
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.